share_log

Morgan Stanley Maintains Underweight on Embecta, Lowers Price Target to $15

Benzinga ·  Oct 18, 2023 11:02

Morgan Stanley analyst Cecilia Furlong maintains Embecta (NASDAQ:EMBC) with a Underweight and lowers the price target from $16 to $15.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment